重磅!科学家质疑巨病毒存在类似CRISPR/Cas的系统

2016-07-08 佚名 生物谷

在很多细菌中发现的CRISPR/Cas免疫防御系统,因其能够简单地而又优雅地编辑宿主基因组,而成为时下最火热的生物技术,在近期产生一大批发现。在今年3月,来自法国艾克斯-马赛大学的Didier Raoult和同事们发表一篇论文,指出一种被称作mimivirus的巨病毒(giant virus)拥有一种类似于CRISPR系统的被称作mimivirus噬病毒体抵抗元件(mimivirus vir

在很多细菌中发现的CRISPR/Cas免疫防御系统,因其能够简单地而又优雅地编辑宿主基因组,而成为时下最火热的生物技术,在近期产生一大批发现。在今年3月,来自法国艾克斯-马赛大学的Didier Raoult和同事们发表一篇论文,指出一种被称作mimivirus的巨病毒(giant virus)拥有一种类似于CRISPR系统的被称作mimivirus噬病毒体抵抗元件(mimivirus virophage resistance element, MIMIVIRE)的噬病毒体抵抗机制(Nature, 10 March 2016, doi:10.1038/nature17146)。而在上个月发表在Virologica Sinica期刊上的一篇论文中,来自法国国家科学研究院(CNRS)的Jean-Michel Claverie和Chantal Abergel对这种观点提出挑战。


Claverie和Abergel在他们的论文中写道,“MIMIVIRE并不类似于CRISPR-Cas系统,并不能够作为一种核酸识别系统发挥作用,也不可能拥有一种真正的适应性免疫系统所拥有的所有性质。”

Claverie和Abergel继续质疑这种噬病毒体抵抗机制到底是不是基于核酸的。他们提出蛋白可能干扰这种抵抗噬病毒体的mimivirus中的噬病毒体复制。

巨病毒因大的尺寸和巨大的基因组而得名。它们栖息在阿米巴变形虫中,而且能够被噬病毒体感染。Raoult和同事们在1992年在研究一座水冷却塔中的肺炎暴发时发现了mimivirus的病毒科Mimiviridae。他们起初把它们错认为是细菌,但是实际上是病毒。

为了验证提出的一个假设:mimivirus拥有一种类似于在细胞中发现的CRISPR/Cas系统的防御机制,Raoult和同事们对45种新的mimivirus毒株的DNA进行测序。他们在60种mimivirus的基因组中寻找能够与在Zamilon---一种感染一些mimivirus毒株(谱系B和C)的噬病毒体---基因组中发现的序列相匹配的序列。他们发现属于谱系A的mimivirus毒株抵抗Zamilon感染,含有Zamilon基因组中的一个重复序列,他们将它称作为MIMIVIRE。当让这个重复序列沉默时,他们发现这能够让这种病毒容易遭受噬病毒体感染。

但是,Claverie和Abergel声称这种mimivirus防御机制一点都不像CRISPR系统。首先,mimivirus基因组和噬病毒体复制发生在相同的地方,“这就不可能获得基于核酸的免疫系统”。再者,CRISPR代表着规律间隔性成簇短回文重复序列,而MIMIVIRE序列“并不是规律间隔性的,而且在两侧也不存在可识别的重复序列”。最后,与MIMIVIRE序列相对应的Zamilon序列缺乏被称作前间隔序列邻近基序(protospacer adjacent motif, PAM)的序列,其中细菌宿主通常利用这一序列区分病原体DNA和它们自己的DNA。

Raoult告诉《科学家》杂志,“它当然不是CRISPR。这是一种类比,而不存在同源性。”

其他没有参与这项研究的病毒学家也赞同Claverie和Abergel提出的批评意见。

来自美国洛克菲勒大学的Luciano Marraffini在发给《科学家》杂志的电子邮件中写道,“尽管MIMIVIRE明显作为一种抗噬病毒体系统发挥作用,但是它似乎缺乏CRISPR-Cas系统的一些典型特征,如存在被短病毒序列间隔开的重复序列阵列,使用短片段RNA作为向导RNA。”

来自美国北卡罗莱纳州立大学的Rodolphe Barrangou对此表示赞同。他在发给《科学家》杂志的电子邮件中写道,认为MIMIVIRE系统类似于CRISPR“走得太远了”。

另一种批评意见最初是由研究论坛PubPeer上的一名匿名的评论员提出的。它指出Raoult和同事们的研究缺乏RNA沉默对照实验,因而不能排除观察不到噬病毒体感染可能是由于mimivirus只是未发生复制。

Barrangou说,“并不存在CRISPR,也不存在Cas。对MIMIVIRE而言,这种类似性存在着偶然因素。我殷切希望科学家们保持开放心态,但是他们未免想象得有点儿太丰富了。”

原始出处

Jean-Michel Claverie, Chantal Abergel.CRISPR-Cas-like system in giant viruses: why MIMIVIRE is not likely to be an adaptive immune system.Virol Sin. 2016 Jun

Anthony Levasseur, Meriem Bekliz, Eric Chabrière, Pierre Pontarotti, Bernard La Scola & Didier Raoult.MIMIVIRE is a defence system in mimivirus that confers resistance to virophage.Nature. 2016 Mar 10;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735078, encodeId=87241e3507861, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Mon Sep 12 21:49:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92579, encodeId=9e6d925e94c, content=学习了,很深入, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 16:15:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275901, encodeId=4fec12e590182, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548860, encodeId=f25f15488609f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624783, encodeId=3c581624e83f2, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=)]
    2016-09-12 saikp
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735078, encodeId=87241e3507861, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Mon Sep 12 21:49:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92579, encodeId=9e6d925e94c, content=学习了,很深入, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 16:15:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275901, encodeId=4fec12e590182, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548860, encodeId=f25f15488609f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624783, encodeId=3c581624e83f2, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=)]
    2016-07-10 oo902

    学习了,很深入

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1735078, encodeId=87241e3507861, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Mon Sep 12 21:49:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92579, encodeId=9e6d925e94c, content=学习了,很深入, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 16:15:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275901, encodeId=4fec12e590182, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548860, encodeId=f25f15488609f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624783, encodeId=3c581624e83f2, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=)]
    2016-07-10 yuandd
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735078, encodeId=87241e3507861, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Mon Sep 12 21:49:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92579, encodeId=9e6d925e94c, content=学习了,很深入, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 16:15:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275901, encodeId=4fec12e590182, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548860, encodeId=f25f15488609f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624783, encodeId=3c581624e83f2, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=)]
    2016-07-10 xxxx1054
  5. [GetPortalCommentsPageByObjectIdResponse(id=1735078, encodeId=87241e3507861, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Mon Sep 12 21:49:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92579, encodeId=9e6d925e94c, content=学习了,很深入, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 16:15:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275901, encodeId=4fec12e590182, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548860, encodeId=f25f15488609f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624783, encodeId=3c581624e83f2, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4120, encryptionId=0333412062, topicName=Cas)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411420689333, createdName=yaanren, createdTime=Sun Jul 10 04:49:00 CST 2016, time=2016-07-10, status=1, ipAttribution=)]
    2016-07-10 yaanren

相关资讯

基因改造病毒治疗脑胶质瘤进入临床试验I期阶段

恶性胶质瘤,最常见的颅内恶性肿瘤 脑癌是指生长在颅腔的新生物,又称颅内肿瘤、脑瘤,可起源于脑、脑膜、神经、血管及脑附件,或由身体的其他组织或脏器转移侵入颅内而形成,大都可产生头痛、颅内高压及局灶性症状。 近年来,颅内肿瘤发病率呈上升趋势,颅内肿瘤约占全身肿瘤的5%,占儿童肿瘤的70%。恶性胶质瘤,源自神经上皮的肿瘤统称为胶质瘤(胶质细胞瘤),占颅脑肿瘤的40-50%,是最常见的颅内恶性

Sci Rep:孕期口腔感染可促进其慢性牙周炎的发生

关于慢性牙周炎孕妇其口腔内疱疹病毒与牙周可疑致病菌的研究甚少。本次病例对照研究旨在探究慢性牙周炎孕妇其牙周可疑致病菌与疱疹病毒之间的潜在关系。研究共纳入36名慢性牙周炎孕妇和36名牙周健康孕妇,收集唾液样品。检测唾液中六种牙周可疑致病菌(牙龈卟啉单胞菌,伴放线聚集杆菌,具核梭杆菌,中间普氏菌,福赛坦氏菌,和齿垢密螺旋体)和三种疱疹病毒(爱泼斯坦-巴尔病毒,人巨细胞病毒和单纯疱疹病毒)。同时收集所有

Nat Immunology:登革热或加重寨卡病情

埃及伊蚊能够传播登革热和寨卡病毒。图片来源:Conrad Guatemala/Flickr 之前曾遭遇过一种肆虐拉丁美洲的疾病的人更容易受到寨卡病毒的侵袭。根据两个独立实验室进行的研究,作为寨卡病毒的“亲戚”,登革热病毒的抗体能够干扰人体免疫系统对寨卡病毒的响应,进而促进病毒的复制能力。这一发现或许有助于解释为什么与该病之前蔓延的其他地区相比,寨卡病毒感染的并发症在南美

NEJM:替诺福韦能有效阻断乙肝母婴间垂直感染

北京佑安医院妇幼中心名誉主任潘启安及副院长段钟平带领科研团队,日前揭示出阻断乙肝的关键一步,为众多乙肝妈妈孕育健康宝宝,阻断母婴传播途径找到最终答案。该研究的论文《替诺福韦预防高病毒载量的乙肝孕妇传播乙肝》,于6月16日刊登在国际顶级医学杂志《新英格兰医学杂志》上,影响因子高达56。 “乙肝目前还不能治愈,而且,抗病毒治疗后仍会存在肝癌风险。”潘启安指出,儿童感染乙肝最常见于母婴传播,如

Nature:揭秘!病毒与宿主免疫系统的精彩“博弈”

病毒必须避开宿主免疫系统从而成功建立感染,最近科学家们发现病毒可以借助另外一种工具挫伤宿主防御。来自费城儿童医院和宾夕法尼亚大学Perelman医学院的研究人员找到了病毒关闭宿主免疫系统预警信号的新机制。该研究由病毒学家Matthew D. Weitzman领导,发表在国际学术期刊Nature上。该研究小组着重研究病毒感染过程中病毒携带DNA与宿主DNA之间的博弈。当病毒将自身DNA导入宿主细胞核